Korean biotech gets OK for stem cell therapy

Korea's MCTT says it has gained Korean regulatory approval to begin marketing a spray-on stem cell therapy that can heal damaged skin in a couple of months. In-house tests of AutoCel are planned over the next few months in advance of marketing efforts. Scientists at the Korea Institute of Radiological and Medical Science developed a process to take skin cells and multiply them by 200 before spraying them back on burns and other injuries.

- read the Korea Times article

Suggested Articles

Loretta Itri, M.D. has been helping Immunomedics out with its troubled antibody-drug conjugate. Now, she’s signing on as its chief medical officer.

Light Chain Bioscience, a unit of Swiss biotech Novimmune, has been handed a nice royalty milestone check from partner Takeda.

The fund received money from Chinese organizations inside and outside the biopharma industry, enabling CICC Capital to ease past its financing goal.